Gumisad, Analiza .
HRN: 26-51-48 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/12/2025
AMPICILLIN 500MG (VIAL)
01/12/2025
01/19/2025
IV
450mg
Q6hrs
Pcap C
Waiting Final Action
01/13/2025
CEFUROXIME 750MG (VIAL)
01/13/2025
01/20/2025
IV
300 Mg
Q8h
PCAP C
Waiting Final Action